Schweiter Technologies
6.2.2026 18:00:00 CET | Globenewswire | Press release
INVITATION TO THE MEDIA & ANALYST CONFERENCE
INVITATION TO THE MEDIA & ANALYST CONFERENCE
INVITATION TO THE MEDIA & ANALYST CONFERENCE
February 27, 2026, 11:00 am
Results 2025 and outlook
Steinhausen, February 6, 2026 – We cordially invite you to the media, analyst and investor conference of Schweiter Technologies. In addition to information on the 2025 results, we are pleased to give you an outlook for 2026.
The media conference will take place on February 27, 2026 at 11:00 a.m. CET at the Hotel Marriott, Neumühlequai 42, in Zurich and will simultaneously be transmitted in a webcast: https://www.webcast-eqs.com/schweiter-2025-results.
Roman Sonderegger (CEO) and Urs Scheidegger (CFO) look forward to your participation. Please confirm your physical participation at the Marriott Hotel no later than February 19, 2026 by email to info@schweiter.com.
Please find the Media release in the PDF attached:
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
The Metals Company19.8.2026 16:25:19 CEST | Press release
NOAA Publishes TMC USA’s Consolidated Application for an Exploration License and Commercial Recovery Permit for TMC USA-A in the Federal Register
Shufti Pro Limited19.8.2026 16:00:00 CEST | Press release
Shufti Helps Obliged Entities Get Ready for the EU AMLR Ahead of the July 2027 Deadline
Cosmos Health Inc.19.8.2026 15:00:00 CEST | Press release
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
Teva Pharmaceutical Industries Ltd19.8.2026 14:30:00 CEST | Press release
U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome
Exclaimer Ltd.19.8.2026 14:00:00 CEST | Press release
Exclaimer Launches MSP Connect to Remove Billing and Management Friction for MSPs
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom